Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0036572 (
seizures
)
80,221
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
E3 ubiquitin ligases are important protein-modifying enzymes involved in the pathogenesis of a variety of neurodegenerative diseases.
F-box and leucine-rich repeat protein 20
(
FBXL20
), an E3 ubiquitin ligase widely expressed in the central nervous system, plays an important role in the ubiquitin-dependent degradation of regulating synaptic membrane exocytosis 1 (RIM1), which is an important factor in the release of synaptic vesicles.
FBXL20
has been associated with a variety of neurodegenerative diseases; thus, we hypothesized that
FBXL20
is involved in the development of epilepsy. Herein, we used immunofluorescence staining, immunohistochemistry and western blotting to determine the expression pattern of
FBXL20
in temporal lobe epilepsy patients and pilocarpine-induced epilepsy animal models. We also injected SD rats with lentivirus-vector mediated overexpression of
FBXL20
. The results showed that
FBXL20
is expressed in the membrane and the cytoplasm of cortical neurons, and overexpression of
FBXL20
decreased the onset level of spontaneous
seizure
, the frequency and duration of
seizures
. Additionally,
FBXL20
protein level was decreased but RIM1 protein level was increased in the epileptic group compared with the LV-
FBXL20
and LV-GFP group. These findings in humans were consistent with the results from a pilocarpine-induced animal model of chronic epilepsy. Thus, abnormal expression of
FBXL20
might play an important role in the development of epilepsy.
...
PMID:Abnormal Expression of FBXL20 in Refractory Epilepsy Patients and a Pilocarpine-Induced Rat Model. 2750 38